Eaton Vance Management Amgen Inc Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Amgen Inc stock. As of the latest transaction made, Eaton Vance Management holds 1,223,375 shares of AMGN stock, worth $340 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

1,223,375

Previous 1,220,210 0.26%

Holding current value

$340 Million

Previous $297 Million 7.12%

% of portfolio

0.41%

Previous 0.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $710,415 - $801,219	3,165 Added 0.26%	1,223,375 $276 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $7.83 Million - $8.72 Million	-33,954 Reduced 2.71%	1,220,210 $297 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $33.3 Million - $36.8 Million	151,724 Added 13.76%	1,254,164 $303 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $7.32 Million - $8.38 Million	36,821 Added 3.46%	1,102,440 $246 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $17.2 Million - $20.2 Million	-81,137 Reduced 7.08%	1,065,619 $224 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $2.99 Million - $3.32 Million	12,803 Added 1.13%	1,146,756 $280 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.31 Million - $1.53 Million	-5,916 Reduced 0.52%	1,133,953 $282 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $10.9 Million - $13 Million	-50,424 Reduced 4.24%	1,139,869 $262 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $1.39 Million - $1.55 Million	-5,927 Reduced 0.5%	1,190,293 $303 Million
Q2 2020 Nov 20, 2020	BUY	$197.81 - $242.74 $28,682 - $35,197	145 Added 0.01%	1,196,220 $282 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $4.26 Million - $5.23 Million	-21,556 Reduced 1.77%	1,196,075 $282 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $35.3 Million - $46.9 Million	193,868 Added 18.94%	1,217,631 $247 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $16.8 Million - $21.5 Million	-88,543 Reduced 7.96%	1,023,763 $247 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $11.8 Million - $14.1 Million	67,821 Added 6.49%	1,112,306 $215 Million
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $4.61 Million - $5.41 Million	-27,674 Reduced 2.58%	1,044,485 $192 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $6.61 Million - $7.45 Million	-36,544 Reduced 3.3%	1,072,159 $204 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $731,796 - $854,241	-4,102 Reduced 0.37%	1,108,703 $216 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $3.62 Million - $4.08 Million	-19,510 Reduced 1.72%	1,112,805 $231 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $4.71 Million - $5.29 Million	-28,366 Reduced 2.44%	1,132,315 $209 Million
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $10.8 Million - $12.6 Million	-63,606 Reduced 5.2%	1,160,681 $198 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $6.39 Million - $7.14 Million	-37,843 Reduced 3.0%	1,224,287 $213 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $211 Million - $241 Million	1,262,130	1,262,130 $235 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Amgen Inc Transaction History